Chronic rhinosinusitis and asthma: epidemiology, pathophysiology, morbidity, treatment
- PMID: 39607835
- DOI: 10.1097/MOO.0000000000001022
Chronic rhinosinusitis and asthma: epidemiology, pathophysiology, morbidity, treatment
Abstract
Purpose of review: Especially with the advent of biologics which have originally been prescribed primarily for pulmonary disease, the interconnections between asthma and chronic rhinosinusitis are becoming even more apparent. Biologics can now also be prescribed for chronic rhinosinusitis in some countries. But what is the epidemiology, pathophysiology and treatment of both diseases?
Recent findings: This review covers the epidemiology, pathophysiology, morbidity and treatment of both diseases. Specifically, this review highlights the interdependencies of both diseases and potential future treatment options.
Summary: This review aims to alert physicians to go beyond treating only one of the diseases, but rather to get a broader picture of the diseases and treatment options.
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.
References
-
- Hastan D, Fokkens WJ, Bachert C, et al. Chronic rhinosinusitis in Europe--an underestimated disease. A GA(2)LEN study. Allergy 2011; 66:1216–1223.
-
- DeConde AS, Soler ZM. Chronic rhinosinusitis: epidemiology and burden of disease. Am J Rhinol Allergy 2016; 30:134–139.
-
- Fokkens WJ, Lund VJ, Hopkins C, et al. European position paper on rhinosinusitis and nasal polyps 2020. Rhinology 2020; 58: (Suppl S29): 1–464.
-
- Hoehle LP, Phillips KM, Bergmark RW, et al. Symptoms of chronic rhinosinusitis differentially impact general health-related quality of life. Rhinology 2016; 54:316–322.
-
- Phillips KM, Hoehle LP, Bergmark RW, et al. Acute exacerbations mediate quality of life impairment in chronic rhinosinusitis. J Allergy Clin Immunol Pract 2017; 5:422–426.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials